Metastatic triple-negative breast carcinoma mimicking melanoma: A potential diagnostic pitfall

被引:0
|
作者
Fliorent, Rebecca [1 ]
Benedetto, Conrad [2 ]
Theroux, Zachary [3 ]
机构
[1] Rowan Univ, Sch Osteopath Med, Stratford, NJ USA
[2] Burke Dermatol, Newark, DE USA
[3] Dermpath Diagnost, 3805 West Chester Pike Bldg D,Suite 120, Newtown Sq, PA 19073 USA
关键词
metastatic breast cancer; mimic; pitfall; PRAME; TNBC; IMMUNOHISTOCHEMISTRY UTILIZATION; PRAME; EXPRESSION; SOX10;
D O I
10.1111/cup.14658
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Melanoma, with its diverse histopathologic characteristics, can mimic both benign nevi and neoplasms of various cell lineages. Immunohistochemistry (IHC) can play a vital role in melanoma diagnosis, particularly when the cell lineage is unclear on hematoxylin and eosin sections. Commonly utilized IHC stains for melanoma diagnosis include SOX10, Melan-A, and S100. A relatively novel stain, PReferentially expressed Antigen in MElanoma (PRAME), is also proving useful in accurate melanoma diagnosis. However, none of these stains are completely specific to melanocytes or melanoma, and misinterpretation can lead to incorrect diagnoses. This report presents a unique case of triple-negative breast carcinoma (TNBC) metastatic to the skin exhibiting histopathologic characteristics similar to melanoma, including positivity for SOX10 and PRAME. Our aim is to highlight TNBC metastatic to the skin as a potential diagnostic pitfall.
引用
收藏
页码:654 / 657
页数:4
相关论文
共 50 条
  • [41] Triple-Negative Breast Carcinoma Current and Emerging Concepts
    Schmadeka, Robert
    Harmon, Bryan E.
    Singh, Meenakshi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (04) : 462 - 477
  • [42] Tackling metastatic triple-negative breast cancer with sacituzumab govitecan
    Schreiber, Anna R.
    Andress, Michelle
    Diamond, Jennifer R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (12) : 1303 - 1311
  • [43] Efficacy of biological agents in metastatic triple-negative breast cancer
    Bramati, Annalisa
    Girelli, Serena
    Torri, Valter
    Farina, Gabriella
    Galfrascoli, Elena
    Piva, Sheila
    Moretti, Anna
    Dazzani, Maria Chiara
    Sburlati, Paola
    La Verde, Nicla Maria
    CANCER TREATMENT REVIEWS, 2014, 40 (05) : 605 - 613
  • [44] Bilateral intra-lymph node Warthin's tumor as a potential diagnostic pitfall mimicking metastatic carcinoma
    Santos-Sousa, Ana Livia
    Camilo-Junior, Deolino Joao
    Conrado-Neto, Sebastiao
    Bernabe, Daniel Galera
    Xavier-Junior, Jose Candido C.
    DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (03) : E59 - E62
  • [45] Metastatic triple-negative breast cancer: A population based study
    Ess, S.
    Jochum, W.
    Oehlschlaegel, C.
    Thuerlimann, B.
    BREAST, 2011, 20 : S78 - S78
  • [46] Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
    Heeke, Arielle L.
    Tan, Antoinette R.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (02) : 537 - 547
  • [47] Metastatic and triple-negative breast cancer: challenges and treatment options
    Sumayah Al-Mahmood
    Justin Sapiezynski
    Olga B. Garbuzenko
    Tamara Minko
    Drug Delivery and Translational Research, 2018, 8 : 1483 - 1507
  • [48] Molecularly targeted therapies for metastatic triple-negative breast cancer
    Soley Bayraktar
    Stefan Glück
    Breast Cancer Research and Treatment, 2013, 138 : 21 - 35
  • [49] A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
    Zeichner, Simon B.
    Terawaki, Hiromi
    Gogineni, Keerthi
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10
  • [50] Novel immunotherapy approach for metastatic triple-negative breast cancer
    Griffin, Paul
    Jain, Riya
    Le, Sean
    Rajapakse, Kyle
    Miller, Wilson
    Andarawewa, Kumari
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)